Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged america invents act · clear
CHRISTY, INC. v. UNITED STATES Before LOURIE, REYNA, and HUGHES. Appeal from the Court of Federal Claims. Summary: The government’s refusal to refund patent issue and maintenance fees after patent claims are canceled during inter partes review does…
This articles is the last of a four-part series examining the USPTO’s role in administering the patent system. Other articles in this series: Part I: Introduction . Part II:Human Resources . Part III: Databases . In previous articles we introduced a…
March 16th, 2013 will see the US embrace a more internationally standard patenting system: first to file (America Invents Act, or AIA). In fact literally every other country uses first to file as opposed to the US first to invent, kind of like that…
The recent decision on Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals LP raises the issue of ‘secret prior art’ and also raises speculation on how (if at all) the America Invents Act will change the patent landscape in this…
On September 8, 2011, the Senate passed the House version of the America Invents Act; it now only awaits the President’s assent. The act brings mixed reactions. Some say they’ve waited too long for it, while for others, a dreaded nightmare is…
